GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (NSE:BROOKS) » Definitions » PB Ratio

Brooks Laboratories (NSE:BROOKS) PB Ratio : 3.48 (As of Jun. 24, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-24), Brooks Laboratories's share price is ₹87.04. Brooks Laboratories's Book Value per Share for the quarter that ended in Mar. 2024 was ₹24.99. Hence, Brooks Laboratories's PB Ratio of today is 3.48.

The historical rank and industry rank for Brooks Laboratories's PB Ratio or its related term are showing as below:

NSE:BROOKS' s PB Ratio Range Over the Past 10 Years
Min: 0.22   Med: 1.43   Max: 4.78
Current: 3.6

During the past 13 years, Brooks Laboratories's highest PB Ratio was 4.78. The lowest was 0.22. And the median was 1.43.

NSE:BROOKS's PB Ratio is ranked worse than
77.01% of 957 companies
in the Drug Manufacturers industry
Industry Median: 1.87 vs NSE:BROOKS: 3.60

During the past 12 months, Brooks Laboratories's average Book Value Per Share Growth Rate was -15.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -7.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -12.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -9.00% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Brooks Laboratories was 57.80% per year. The lowest was -18.40% per year. And the median was 2.70% per year.

Back to Basics: PB Ratio


Brooks Laboratories PB Ratio Historical Data

The historical data trend for Brooks Laboratories's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brooks Laboratories PB Ratio Chart

Brooks Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 1.91 2.06 2.08 3.75

Brooks Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.08 3.00 - 3.75

Competitive Comparison of Brooks Laboratories's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Brooks Laboratories's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brooks Laboratories's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brooks Laboratories's PB Ratio distribution charts can be found below:

* The bar in red indicates where Brooks Laboratories's PB Ratio falls into.



Brooks Laboratories PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Brooks Laboratories's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=87.04/24.988
=3.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Brooks Laboratories  (NSE:BROOKS) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Brooks Laboratories PB Ratio Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Brooks Laboratories (NSE:BROOKS) Business Description

Traded in Other Exchanges
Address
Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093
Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. It has manufacturing sites located in Baddi, Himachal Pradesh, and Vadodara, Gujarat. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories (NSE:BROOKS) Headlines

No Headlines